Lumida
/GL
⌘K
Globe Life Inc

Globe Life Inc

GL
$171.17USD+0.22%+0.37 today

MARKET CAP

13.2B

P/E (TTM)

12.1x

FWD P/E

DAY RANGE

$171 – $174

52W RANGE

$128
$192

AI Summary

Stalk
TrimMedium

GL is in a Stage 4 distribution phase with active Lower Highs & Lower Lows confirming supply dominance and a bearish medium-term bias. Short-term timing is unfavorable as price trades below declining EMAs in an oversold context without any reversal signals. Execution should be deferred, trimming into rallies near the 9/20 EMA resistance zone around 172–174. The long-term uptrend remains intact above the 200-day SMA, providing structural support unless decisively broken.

  • Q2 2026 net income rose 20% YoY to $288M, driven by 16% health premium growth ($437M).
  • Management forecasts ~7% total premium revenue growth in 2026, underscoring durable momentum.
  • Negative growth outlook as admin expenses rise 8% YoY and investment income falls 8% to $31M.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$5.1B$5.2B$5.4B$5.8B$6.0B
YoY %+7.9%+2.2%+4.2%+6.1%+3.7%
P / Sales1.9x2.3x2.2x1.7x1.9x
EV / Sales6.0x6.5x6.5x5.8x6.0x
Gross Profit, Adj.$2.1B$1.5B$2.2B$2.5B$2.7B
YoY %+66.3%-27.6%+42.5%+12.3%+7.6%
Margin %41.8%29.6%40.5%42.8%44.4%
EV / Gross Profit14.4x21.8x16.0x13.6x13.6x
EBITDA, Adj.$1.7B$1.5B$1.7B$1.9B$2.0B
YoY %+7.5%-8.0%+8.8%+11.2%+8.7%
Margin %32.8%29.5%30.8%32.3%33.8%
EV / EBITDA18.3x21.9x21.0x18.0x17.9x
EBIT$1.4B$1.2B$1.3B$1.5B$1.6B
YoY %+38.1%-12.2%+8.7%+12.1%+8.5%
Margin %26.6%22.8%23.8%25.2%26.3%
EV / EBIT22.6x28.3x27.2x23.1x23.0x
Net Income$1.0B$894.4M$970.8M$1.1B$1.2B
YoY %+40.9%-13.3%+8.5%+10.3%+8.4%
Net Margin20.2%17.1%17.8%18.5%19.4%
EPS (GAAP)$9.99$9.04$10.07$11.94$14.07
YoY %+46.5%-9.5%+11.4%+18.6%+17.8%